Literature DB >> 17909035

Cancer resistance in transgenic mice expressing the SAC module of Par-4.

Yanming Zhao1, Ravshan Burikhanov, Shirley Qiu, Subodh M Lele, C Darrell Jennings, Subbarao Bondada, Brett Spear, Vivek M Rangnekar.   

Abstract

Prostate apoptosis response-4 (Par-4) is a tumor-suppressor protein that induces apoptosis in cancer cells, but not in normal/immortalized cells. The cancer-specific proapoptotic action of Par-4 is encoded in its centrally located SAC domain. We report here the characterization of a novel mouse model with ubiquitous expression of the SAC domain. Although SAC transgenic mice displayed normal development and life span, they were resistant to the growth of spontaneous, as well as oncogene-induced, autochthonous tumors. Resistance to tumorigenesis was linked to inhibition of nuclear factor-kappaB activity and induction of apoptosis by the SAC domain. Collectively, our findings provide genetic evidence that the SAC domain of Par-4 confers cancer resistance in transgenic mice without compromising normal viability or aging, and may have therapeutic significance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909035     DOI: 10.1158/0008-5472.CAN-07-2124

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

Review 1.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

2.  Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically.

Authors:  Antonio Franchitto; Alessia Torrice; Rossella Semeraro; Cristina Napoli; Gennaro Nuzzo; Felice Giuliante; Gianfranco Alpini; Guido Carpino; Pasquale Bartolomeo Berloco; Luciano Izzo; Antonio Bolognese; Paolo Onori; Anastasia Renzi; Alfredo Cantafora; Eugenio Gaudio; Domenico Alvaro
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Authors:  Anindya Goswami; Shirley Qiu; Thomas S Dexheimer; Padhma Ranganathan; Ravshan Burikhanov; Yves Pommier; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.

Authors:  Ravshan Burikhanov; Yanming Zhao; Anindya Goswami; Shirley Qiu; Steven R Schwarze; Vivek M Rangnekar
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

5.  Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals.

Authors:  Young Seok Ju; Jong-Il Kim; Sheehyun Kim; Dongwan Hong; Hansoo Park; Jong-Yeon Shin; Seungbok Lee; Won-Chul Lee; Sujung Kim; Saet-Byeol Yu; Sung-Soo Park; Seung-Hyun Seo; Ji-Young Yun; Hyun-Jin Kim; Dong-Sung Lee; Maryam Yavartanoo; Hyunseok Peter Kang; Omer Gokcumen; Diddahally R Govindaraju; Jung Hee Jung; Hyonyong Chong; Kap-Seok Yang; Hyungtae Kim; Charles Lee; Jeong-Sun Seo
Journal:  Nat Genet       Date:  2011-07-03       Impact factor: 38.330

6.  Systemic Par-4 inhibits non-autochthonous tumor growth.

Authors:  Yanming Zhao; Ravshan Burikhanov; Jason Brandon; Shirley Qiu; Brent J Shelton; Brett Spear; Subbarao Bondada; Scott Bryson; Vivek M Rangnekar
Journal:  Cancer Biol Ther       Date:  2011-07-15       Impact factor: 4.742

7.  A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.

Authors:  Nikhil Hebbar; Ravshan Burikhanov; Nidhi Shukla; Shirley Qiu; Yanming Zhao; Kojo S J Elenitoba-Johnson; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2017-06-16       Impact factor: 12.701

Review 8.  A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.

Authors:  Reyaz Ur Rasool; Debasis Nayak; Souneek Chakraborty; Archana Katoch; Mir Mohd Faheem; Hina Amin; Anindya Goswami
Journal:  Clin Exp Metastasis       Date:  2016-08-27       Impact factor: 5.150

9.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

10.  Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival.

Authors:  X Chen; A A Sahasrabuddhe; P Szankasi; F Chung; V Basrur; V M Rangnekar; M Pagano; M S Lim; K S J Elenitoba-Johnson
Journal:  Cell Death Differ       Date:  2014-07-04       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.